The Effects of Dabigatran and Rivaroxaban on Markers of Polymorphonuclear Leukocyte Activation
Dabigatran is an oral direct thrombin inhibitor, and rivaroxaban, a factor Xa inhibitor. Dabigatran has been implicated in the etiology of acute coronary syndromes and as these occur following inflammatory changes in the endothelium, we investigated the inflammatory potential of these agents in vitr...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2018-05-01
|
| Col·lecció: | Pharmaceuticals |
| Matèries: | |
| Accés en línia: | http://www.mdpi.com/1424-8247/11/2/46 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|